Search alternatives:
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
-
12161
Table_2_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12162
Table_1_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12163
Image_9_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12164
Image_3_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12165
Image_8_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12166
Table_6_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12167
-
12168
Image_7_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12169
Table_4_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12170
Image_5_High Dose Vitamin D3 Supplementation Is Not Associated With Lower Mortality in Critically Ill Patients: A Meta-Analysis of Randomized Control Trials.pdf
Published 2022“…The use of a high dose of vitamin D3 in critically ill patients could not decrease the mortality truncated to day 28 (RR 0.93, 95% CI 0.78–1.11, P = 0.43) or day 90 (RR 0.91, 95% CI 0.79–1.05, P = 0.21). …”
-
12171
Table_8_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX
Published 2023“…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
-
12172
-
12173
-
12174
-
12175
-
12176
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random...
Published 2023“…The primary outcome was accessed in the “per protocol” population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization’s (WHO) seven-category ordinal scale by day 28. …”
-
12177
Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last?
Published 2022“…The mean analgesic intake before BoNTA was 11.48±4.68 tablets/month, while it decreased to 6.53±2.72 tablets/month in the first month (p<0.001) and 5.40±2.46 tablets/month in the second month (p<0.001). …”
-
12178
-
12179
-
12180